Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

01.04.16	Pfizer Issues Statement On Press Release On Drug Pricing (RTTNews)
31.03.16	FTC Seeks Addl Information On Pfizer - Allergan Deal (RTTNews)
24.03.16	Odyssey Hits The Mark, SPHS Awaits Data In Q2, TEVA Breathes Easy (RTTNews)
21.03.16	AFFX Says No To Rival Bid, AUPH Awaits Data In Q3, Eagle Flies Down (RTTNews)
16.03.16	Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO (Businesswire)
12.03.16	FDA Approves Pfizer's Xalkori To Treat Lung-cancer Patients With Gene Alteration (RTTNews)
09.03.16	Pfizer To Buy $5 Bln Of Common Stock Under Accelerate Share Repurchase (RTTNews)
04.03.16	CERS Gets A Lift From Blood Bank Deal, VTAE On Track, TBRA Awaits Data In Q2 (RTTNews)
03.03.16	Merck, Pfizer, Verastem Combination Trial Of Avelumab &VS-6063 In Ovarian Cancer (RTTNews)
03.03.16	Merck, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer (Businesswire)
03.03.16	Merck KgaA, Pfizer, Verastem Agree To Combination Trial Of Avelumab And VS-6063 (RTTNews)
03.03.16	OPXA Hands Out Pink Slips, KOOL Not So Hot, Time To Follow RVNC (RTTNews)
25.02.16	Nuvo To Split Into Two, BSPM Regains Compliance, PFE Gets FDA Nod (RTTNews)
22.02.16	FDA Expands Use Of Pfizer's Ibrance, Attack On Titan, Spectrum Gets FDA Date (RTTNews)
16.02.16	Pfizer's Wyeth Agrees To Pay $784.6 Mln To Resolve Protonix Claims (RTTNews)
12.02.16	Sandoz Acquires Pfizer's Biosimilar Infliximab In EEA (RTTNews)
08.02.16	Pfizer Names Leadership Team For Combined Company Upon Close Of Allergan Deal (RTTNews)
08.02.16	Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction (Businesswire)
02.02.16	Pfizer Q4 Profit Down, Adj. EPS Tops View; Sees FY16 Results Below Forecast (RTTNews)
02.02.16	Pfizer Inc. Earnings Decline 4% In Q4 (RTTNews)
01.02.16	Bristol-Myers, Pfizer Join With Portola To Develop Andexanet Alfa In Japan (RTTNews)
11.01.16	HemoShear Therapeutics To Initiate Safety Collaboration With Pfizer (RTTNews)
08.01.16	Pfizer Collaborates With Adaptive To Advance Novel Immuno-Oncology Solutions (RTTNews)
07.01.16	Dietary Supplements Containing Kratom Seized On Potential Addictive Quality (RTTNews)
05.01.16	EXEL Shines On Meteor Impact, GILD Gets FDA Date, VCEL Moving Ahead (RTTNews)
04.01.16	Merck, Pfizer And Syndax Collaborate To Evaluate Avelumab With Entinostat (RTTNews)
04.01.16	Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer (Businesswire)
04.01.16	Pfizer Licenses Access To KineMed Platform - Quick Facts (RTTNews)
01.01.16	Looking For Novel New Drug Approvals Of 2015? Here's The List... (RTTNews)
22.12.15	Merck KGaA, Pfizer Initiate Two Additional Phase III Trials Of Avelumab (RTTNews)
22.12.15	Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab (Businesswire)
21.12.15	Alibaba Names Bassiur VP, Head Of Global Intellectual Property Enforcement (RTTNews)
14.12.15	FDA Okays New Oral Therapy To Treat ALK-positive Lung Cancer (RTTNews)
10.12.15	Pfizer Says FDA Accepts IBRANCE SNDA - Quick Facts (RTTNews)
09.12.15	Merck and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers (Businesswire)
09.12.15	Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers (Businesswire)
08.12.15	BioAtla Reaches License & Option Deal With Pfizer On Antibody Therapeutics (RTTNews)
30.11.15	Sosei Unit Heptares Signs Drug Discovery Deal With Pfizer - Quick Facts (RTTNews)
25.11.15	Pfizer Says Phase 3 Study On LYRICA Fails To Meet Primary Efficacy Endpoint (RTTNews)
25.11.15	Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products (Businesswire)
25.11.15	Pfizer: European Commission Approves Expanded Use Of XALKORI - Quick Facts (RTTNews)
24.11.15	FDA Approves Bristol-Myers's Opdivo To Treat Advanced Form Of Kidney Cancer (RTTNews)
23.11.15	Pfizer And Allergan To Merge In $160 Bln Deal (RTTNews)
23.11.15	Pfizer and Allergan to Combine (Businesswire)
22.11.15	Report : Pfizer And Allergan Set To Strike Merger Deal Worth More Than $150 Bln (RTTNews)
20.11.15	WSJ : Allergan-Pfizer Discussions Include Allergan As Possible Buyer (RTTNews)
19.11.15	Pfizer Reportedly In Advanced Talks To Buy Allergan (RTTNews)
18.11.15	Pfizer: XALKORI Phase 3 Study Meets Primary Objective - Quick Facts (RTTNews)
18.11.15	Merck & Pfizer Announce Breakthrough Therapy Designation For Avelumab (RTTNews)
18.11.15	Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

28.12.24		Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen
27.12.24		Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag
27.12.24		Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste
27.12.24		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge
27.12.24		Börse London in Grün: FTSE 100 zum Ende des Freitagshandels freundlich
27.12.24		Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

28.12.24

Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen

27.12.24

Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus

27.12.24

BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

27.12.24

Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag

27.12.24

Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste

27.12.24

Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

27.12.24

Börse London in Grün: FTSE 100 zum Ende des Freitagshandels freundlich

27.12.24

Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten